Payam Nahid

About Payam Nahid

Payam Nahid, With an exceptional h-index of 44 and a recent h-index of 33 (since 2020), a distinguished researcher at University of California, San Francisco,

His recent articles reflect a diverse array of research interests and contributions to the field:

Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center …

Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the …

Blazing the trail for innovative tuberculosis diagnostics

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

Nine-month, all-oral regimens for rifampin-resistant tuberculosis

Cost-effectiveness of Low-complexity Screening Tests in Community-based Case-finding for Tuberculosis

Environmental Determinants of Lung Development in Healthy Children With and Without Tuberculosis (TB) Infection in Vietnam

Climate and Pollutant Determinants of Incident TB Infection Among Children in Vietnam: A Prospective Cohort Study

Payam Nahid Information

University

Position

___

Citations(all)

12225

Citations(since 2020)

6883

Cited By

7873

hIndex(all)

44

hIndex(since 2020)

33

i10Index(all)

94

i10Index(since 2020)

80

Email

University Profile Page

Google Scholar

Top articles of Payam Nahid

Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center …

PLoS medicine

2024/2/20

Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the …

The Lancet Global Health

2024/2/1

Blazing the trail for innovative tuberculosis diagnostics

2024/2

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

The Lancet Respiratory Medicine

2024/2/1

Nine-month, all-oral regimens for rifampin-resistant tuberculosis

medRxiv

2024

Cost-effectiveness of Low-complexity Screening Tests in Community-based Case-finding for Tuberculosis

Clinical Infectious Diseases

2024/1/15

Environmental Determinants of Lung Development in Healthy Children With and Without Tuberculosis (TB) Infection in Vietnam

2024/5

Climate and Pollutant Determinants of Incident TB Infection Among Children in Vietnam: A Prospective Cohort Study

2024/5

Tuberculosis treatment monitoring tests during routine practice: study design guidance

Clinical Microbiology and Infection

2024/1/3

Payam Nahid
Payam Nahid

H-Index: 31

Facilitators and barriers to adolescent participation in a TB clinical trial

The International Journal of Tuberculosis and Lung Disease

2024/5/1

C-reactive protein-based tuberculosis triage testing: a multi-country diagnostic accuracy study

medRxiv

2024

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis

Clinical Infectious Diseases

2024/3/11

Longitudinal analysis of host protein serum signatures of treatment and recovery in pulmonary tuberculosis

Plos one

2024/2/29

Payam Nahid
Payam Nahid

H-Index: 31

Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country …

Trials

2023/11/30

Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis

The Lancet Respiratory Medicine

2023/3/23

Andrea Benedetti
Andrea Benedetti

H-Index: 47

Payam Nahid
Payam Nahid

H-Index: 31

Patient-reported symptom and health-related quality-of-life validation and responsiveness during the first 6 months of treatment for Mycobacterium avium complex pulmonary disease

Chest

2023/7/1

A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials

American journal of respiratory and critical care medicine

2023/5/15

Effectiveness and pharmacokinetic exposures of first-line drugs used to treat drug-susceptible tuberculosis in children: a systematic review and meta-analysis

2023/5/1

Kendra Radtke
Kendra Radtke

H-Index: 4

Payam Nahid
Payam Nahid

H-Index: 31

Safety and tolerability of adjunctive linezolid with high or standard dose rifampin for the treatment of adults with HIV-associated tuberculous meningitis in Uganda …

2023/4/25

Payam Nahid
Payam Nahid

H-Index: 31

See List of Professors in Payam Nahid University(University of California, San Francisco)